Kevin R. Sayer
President CEO and Chairman of at DexCom Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: DexCom Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
DexCom Inc. May 27, 202697.8%
-
DexCom Inc. May 8, 202594.9%
-
DexCom Inc. May 22, 202494.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 20, 2026 | DexCom Inc. | Open-market sale | −19,308 | $89.71 | $1,732,121 |
| Aug 20, 2026 | DexCom Inc. | Open-market sale | −7,351 | $90.78 | $667,324 |
| Aug 20, 2026 | DexCom Inc. | Open-market sale | −97 | $91.41 | $8,867 |
| Jul 20, 2026 | DexCom Inc. | Open-market sale | −26,756 | $76.32 | $2,042,018 |
| Jul 6, 2026 | DexCom Inc. | Open-market sale | −26,756 | $72.00 | $1,926,432 |
| May 21, 2026 | DexCom Inc. | Open-market sale | −26,759 | $72.00 | $1,926,648 |
| Mar 8, 2026 | DexCom Inc. | Grant or award | +32,749 | — | — |
| Mar 8, 2026 | DexCom Inc. | Shares withheld for tax | −32,498 | $68.10 | $2,213,114 |
| Jan 29, 2026 | DexCom Inc. | Grant or award | +71,218 | — | — |
| Jan 29, 2026 | DexCom Inc. | Shares withheld for tax | −34,257 | $73.36 | $2,513,094 |
| Mar 12, 2025 | DexCom Inc. | Open-market sale | −32,498 | $70.38 | $2,287,209 |
| Mar 8, 2025 | DexCom Inc. | Grant or award | +85,490 | — | — |
| Jan 29, 2025 | DexCom Inc. | Open-market sale | −33,359 | $86.91 | $2,899,231 |
| Jan 28, 2025 | DexCom Inc. | Grant or award | +68,503 | — | — |
| Apr 8, 2024 | DexCom Inc. | Open-market sale | −27,272 | $137.96 | $3,762,445 |
Questions about Kevin R. Sayer
What boards is Kevin R. Sayer on?
Kevin R. Sayer sits on the boards of DexCom Inc. and Guardant Health Inc.
What company is Kevin R. Sayer the CEO of?
Kevin R. Sayer is President CEO and Chairman of of DexCom Inc.
How long has Kevin R. Sayer served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.